Guido Grassi Selected Research

lercanidipine

10/2017	Lercanidipine in the Management of Hypertension: An Update.
3/2016	Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
1/2016	Lercanidipine/enalapril combination in the management of obesity-related hypertension.
1/2006	Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guido Grassi Research Topics

Disease

128	Hypertension (High Blood Pressure) 11/2022 - 03/2002
31	Heart Failure 01/2022 - 06/2004
30	Obesity 01/2022 - 09/2003
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2021 - 11/2006
19	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 09/2002
13	Essential Hypertension 12/2021 - 10/2002
12	Chronic Renal Insufficiency 11/2022 - 07/2009
12	Stroke (Strokes) 11/2022 - 06/2002
10	Insulin Resistance 01/2022 - 09/2003
9	Renal Insufficiency (Renal Failure) 01/2021 - 09/2004
9	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 08/2008
7	COVID-19 01/2022 - 01/2020
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2011
7	Hypertrophy 01/2021 - 01/2006
7	Disease Progression 01/2020 - 04/2009
7	Cardiomegaly (Heart Hypertrophy) 09/2015 - 11/2006
6	Body Weight (Weight, Body) 11/2021 - 08/2005
6	Atrial Fibrillation 06/2021 - 03/2003
6	Weight Loss (Weight Reduction) 01/2021 - 04/2010
5	Myocardial Infarction 04/2022 - 12/2019
4	Fibrosis (Cirrhosis) 11/2021 - 05/2005
4	Diabetes Mellitus 01/2020 - 08/2008
4	Atherosclerosis 01/2020 - 11/2012
4	Obstructive Sleep Apnea 01/2019 - 08/2005
4	Isolated Systolic Hypertension 01/2018 - 06/2015
4	Abdominal Obesity 06/2015 - 12/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2022 - 01/2015
3	Hyperuricemia 01/2022 - 11/2017
3	Left Ventricular Dysfunction 01/2022 - 08/2011
3	Kidney Diseases (Kidney Disease) 01/2022 - 10/2018
3	Carotid Artery Diseases 01/2021 - 06/2009
3	Overweight 01/2019 - 07/2009
3	White Coat Hypertension 08/2015 - 08/2011
3	Masked Hypertension 07/2015 - 08/2009
3	Metabolic Diseases (Metabolic Disease) 10/2010 - 01/2006
2	Coronary Disease (Coronary Heart Disease) 04/2022 - 12/2012
2	Hypercholesterolemia 03/2022 - 06/2005
2	Atherosclerotic Plaque (Atheroma) 03/2022 - 06/2021
2	Takotsubo Cardiomyopathy 01/2022 - 01/2022
2	Periodontitis 09/2021 - 09/2021
2	Hemorrhage 06/2021 - 03/2017
2	Right Ventricular Hypertrophy 01/2021 - 10/2014
2	Iron Overload 11/2020 - 03/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 03/2009

Drug/Important Bio-Agent (IBA)

46	Antihypertensive Agents (Antihypertensives)IBA 07/2022 - 03/2002
36	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021 - 03/2003
19	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2021 - 09/2004
17	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 09/2003
15	Uric Acid (Urate)IBA 11/2022 - 06/2014
13	CholesterolIBA 01/2021 - 06/2005
12	Blood Glucose (Blood Sugar)IBA 01/2021 - 06/2005
12	Pharmaceutical PreparationsIBA 01/2020 - 09/2002
11	DiureticsIBA 11/2022 - 09/2003
10	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021 - 01/2016
8	LDL CholesterolIBA 11/2022 - 09/2014
8	LipidsIBA 03/2022 - 01/2010
7	Triglycerides (Triacylglycerol)IBA 01/2022 - 05/2010
7	Drug CombinationsIBA 01/2021 - 09/2004
7	Retinaldehyde (Retinal)IBA 01/2021 - 05/2006
6	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 06/2005
6	Angiotensin Receptor AntagonistsIBA 11/2021 - 09/2003
6	ReninIBA 01/2019 - 09/2004
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2008
5	Insulin (Novolin)FDA Link 01/2020 - 09/2003
5	AngiotensinsIBA 01/2019 - 03/2006
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2019 - 01/2006
5	AldosteroneIBA 01/2018 - 05/2005
4	lercanidipineIBA 10/2017 - 01/2006
4	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2017 - 09/2003
4	LeptinIBA 08/2015 - 11/2006
3	Ethanol (Ethyl Alcohol)IBA 11/2022 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 11/2011
3	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 02/2015
3	SodiumIBA 01/2022 - 10/2010
3	CreatinineIBA 01/2022 - 01/2019
3	CatecholaminesIBA 01/2022 - 10/2019
3	Biological ProductsIBA 09/2021 - 11/2017
3	Atenolol (Tenormin)FDA LinkGeneric 01/2020 - 12/2003
3	Peptides (Polypeptides)IBA 01/2017 - 09/2011
3	Nebivolol FDA Link 01/2017 - 12/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 01/2019
2	SolutionsIBA 05/2022 - 02/2004
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 10/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 02/2015
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 11/2019
2	AlbuminsIBA 01/2022 - 01/2020
2	CalciumIBA 01/2022 - 01/2022
2	IvabradineIBA 01/2022 - 01/2015
2	Mineralocorticoid Receptor AntagonistsIBA 11/2021 - 12/2012
2	PotassiumIBA 11/2021 - 01/2020
2	AnticoagulantsIBA 01/2021 - 01/2019
2	ThiazidesIBA 01/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2018
2	lacidipineIBA 01/2020 - 01/2019

Therapy/Procedure

32	Therapeutics 01/2022 - 11/2004
15	Denervation 01/2021 - 01/2012
4	Secondary Prevention 03/2022 - 06/2002
3	Glycemic Control 01/2021 - 12/2013
3	Bariatric Surgery 10/2014 - 06/2012
2	Kidney Transplantation 01/2021 - 01/2021